Early Remission in Focal Tardive Dystonia Associated with the Use of Neuroleptic Medication: A Rare Case Report and Review of Literature

Tardive dystonia is a movement disorder which develops with twisting of one part of the body or abnormal posture because of severe muscle contractions. The most important factor in the occurrence of tardive dystonia is the use of antipsychotic medication. Tardive dystonia associated with long-term use of antipsychotic drugs may be focal, segmental or generalised. When tardive dystonia has occurred once, there is a tendency for it to be permanent and complete recovery is rare. The aim of this paper was to present a case of neuroleptic drugassociated tardive dystonia with focal involvement where early remission was observed and thus draw attention to the necessity of considering physical therapy approaches in addition to medication in the treatment choices.

PDF

___

1. Özdemir C, Eryılmaz M. Geç distoni, geç diskinezi ve tedavi yaklaşımları. Klinik Psikofarmakoloji Bülteni. 1999;9(3):152-8.

2. Kiriakakis V, Bhatia KP, Quinn NP, Marsden CD. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain. 1998;121(Pt11):2053-66.

3. Lencer R, Eismann G, Kasten M, Kabakci K, Geithe V, Grimm J, Klein C. Family history of primary movement disorders as a predictor for neuroleptic-induced extrapyramidal symptoms. Br J Psychiatry. 2004;185:464-71.

4. Öztürk O, Kurt E, Oral T. İlaca bağlı geç başlangıçlı hareket bozuklukları. Klinik Psikofarmaktoloji Bülteni. 2006;16(4):263-73.

5. Francisco GE, Kathari S, Schiess MC, Kaldis T. Parkinson hastalığı ve diğer hareket bozukluğu olan hastaların rehabilitasyonu. In: DeLisa JA, Gans BM, Walsh NE, eds, Fiziksel Tıp ve Rehabilitasyon İlkeler ve Uygulamalar. 4. baskı. Ankara: Güneş Tıp Kitabevleri, 2007;809-28.

6. Saulino M, Doherty J, Fried G. Santral sinir sisteminin dejeneratif hareket bozukluklarında rehabilitasyon sorunları. In: Braddom RL, ed, Fiziksel Tıp ve Rehabilitasyon. Üçüncü baskı. Ankara: Güneş Tıp Kitabevleri, 2010;1213-21.

7. Bakker PR, de Groot IW, van Os J, van Harten PN. Long-stay psychiatric patients: A prospective study revealing persistent antipsychotic-induced movement disorder. Plos One. 2011;6(10):e25588.

8. Van Harten PN, Kahn RS: Tardive dystonia. Schizophr Bull. 1999;25(4):741-8.

9. Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry. 2008;21(2):151-6.

10. Kissling W, Heres S, Lloyd K, Sacchetti E, Bouhours P, Medori R, Llorca PM. Direct transition to long-acting risperidone-analysis of long-term efficacy. J Psychopharmacol. 2005;19(5 Suppl):15-21.

11. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antiphsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry. 2002;159(1):103-8.

12. Brugnoli R, Novick D, Belger M, Brown J, Germani S, Donda P, Rossi A, Pancheri P, The Italian SOHO Study Group. Effectiveness of antipsychotic treatment for schizophrenia: Italian results of the pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study after 12 months. Giorn Ital Psicopat. 2006;12(3):283-92.

13. Vasilyeva I, Biscontri RG, Enns MW, Metge CJ, Alessi-Severini S: Movement disorders in elderly users of risperidone and first generation antipsychotic agents: A Canadian population-based study. PLoS One. 2013;8(5):e64217.

14. Torres-Russotto D, Perlmutter JS: Focal dystonias of the hand and upper extremity. J Hand Surg Am. 2008;33(9):1657-8.

15. Weiss EM, Hershey T, Karimi M, Racette B, Tabbal SD, Mink JW, Paniello RC, Perlmutter JS. Relative risk of spread of symptoms among the focal onset primary dystonias. Mov Disord. 2006;21(8):1175-81.

16. Jaffe ME, Simpson GM: Reduction of tardive dystonia with olanzapine. Am J Pscyhiatry. 1999; 156(12):2016.

17. Raucverger B, Isakov V, Jabarin M. Olanzapine induced tardive dystonia successfully treated by tetrabenazine. J Neuropsychiatry Clin Neurosci. 2007;19(4):484-5.

18. Uzun Adatepe N. Ekstremite ve gövde distonileri; botulinum toksin uygulamaları. Nöropsikiyatri Arşivi. 2010;47(1):19-26.

19. Tassorelli C, Mancini F, Balloni L, Pacchetti C, Sandrini G, Nappi G, Martignoni E. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Mov Disord. 2006;21(12):2240-3.

20. Queiroz MA, Chien HF, Sekeff-Sallem FA, Barbosa ER. Physical therapy program for cervical dystonia: a study of 20 cases. Funct Neurol. 2012;27(3):187-92.

21. Yasui-Furukori N, Kikuchi A, Katagai H, Kaneko S. The effects of electroconvulsive therapy on tardive dystonia or dyskinesia induced by psychotropic medication: a retrospective study. Neuropsychiatr Dis Treat. 2014;10:1209-12.